LLY
WAITEli Lilly and Company
$1148.84
-0.53%delayed
News ▲ · Trend ▼ · inside triggers –
Expected move (1d)
▼ $1112.46to$1185.22 ▲
ATR ±$36.38 (+3.17%)Implied ±$86.40 (+7.52%)
Entry Reference
Price / prev close$1148.84 / $1154.97
Day range$1119.00 – $1150.63
52-wk range$623.78 – $1249.45(84%)
Volume vs avg0.96×
ATR (14d)$36.38
MA 8 / 21$1184.62 / $1186.16
MA 50 / 200$1147.32 / $1024.79
Call ▲ / Put ▼ trigger$1163.56 / $1146.38
+1 / +2 ATR$1185.22 / $1221.61
-1 / -2 ATR$1112.46 / $1076.07
Support: 1134.40 1079.22 1052.15
Resistance: 1149.10 1182.73 1249.45
Near-the-money contracts
exp 2026-08-07Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 1135 | $49.60 | 67% | 0.58 | -3.39 | 5 |
| 1140 | $46.50 | 66% | 0.56 | -3.38 | 22 |
| 1145 | $44.40 | 67% | 0.54 | -3.43 | 9 |
| 1150 | $43.30 | 69% | 0.52 | -3.54 | 49 |
| 1155 | $39.38 | 67% | 0.49 | -3.42 | 21 |
| 1160 | $38.15 | 68% | 0.48 | -3.49 | 156 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 1140 | $37.50 | 66% | -0.44 | -3.22 | 236 |
| 1145 | $40.25 | 67% | -0.46 | -3.26 | 202 |
| 1150 | $43.10 | 67% | -0.48 | -3.29 | 180 |
| 1152.5 | $43.75 | 66% | -0.50 | -3.24 | 9 |
| 1155 | $44.50 | 65% | -0.51 | -3.19 | 190 |
| 1157.5 | $46.50 | 66% | -0.52 | -3.24 | 23 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- Novo Nordisk (NVO) Stock Looks Below Fair Value Despite Recent Setbacks2h ago
- Prediction: Eli Lilly Will Be Worth $2 Trillion by 20313h ago
- SpaceX's First Earnings Post IPO12h ago
- NVO Stock Ends Three-Month Winning Streak As Novo Nordisk’s Key Heart Drug Flops, Competition Goes To Court23h ago
- Beyond the Mag 7: Rising Q3 Estimates Signal a Market-Wide Earnings Expansion1d ago
- Dow Jones Futures: Market Rebounds, Now Watch For This; SpaceX, AMD, Sandisk, Eli Lilly Earnings Loom1d ago
- Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said.1d ago
- Jim Cramer says one popular stock is meant to be owned, not traded1d ago
- Mizuho's Holz talks Novo Nordisk shares tumbling after its heart medicine fails trial1d ago
- Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore.1d ago
- Novo Nordisk’s Heart Drug Suffers a Major Setback. What It Means for the Stock.1d ago
- Novo Nordisk vs Eli Lilly: The Better Buy Before Earnings1d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.